The XBI biotech index hit its lowest point since 2018. No one knows what comes next.

Off antibiotics, Biotech, biotechnology, cancer, drug development, drug pricing, finance, Health, health care, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, everyone. Damian here with a look at biotech’s latest nadir, the virtues of Neanderthal DNA, and the sudden success of a decades-old idea in oncology.

Read the rest…

Read Original Article: The XBI biotech index hit its lowest point since 2018. No one knows what comes next. »

About The Author